Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Banook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn moreVascotube GmbH has been acquired by Cirtec Medical Systems, LLC
Ordito GmbH, a private investment company, has sold Vascotube GmbH, a leading German manufacturer of high quality nitinol tubing, to 3i-backed Cirtec Medical Systems, LLC (Cirtec), a provider of design and contract manufacturing services for implantable and minimally invasive surgical devices. Financial details will remain confidential.
Learn moreBluebird Care has been acquired by Interim Healthcare Inc.
US-based care-at-home franchisor Interim Healthcare Inc. has acquired Bluebird Care, based in the UK, a national provider of care in the home. Financial details have not been provided.
Learn more
Jan De Backer
CEO, Fluidda NV
Read more
New chapters, global ambitions: mid-market M&A in Q4
QUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins' clients completed 93 transactions across sectors and regions, highlighting how business leaders are using M&A to drive growth, succession and strategic change.
Learn more
Meet our global industry specialists
